← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Transcode Therapeutics, Inc.
Boston, MA
$4,308,833
Total funding
2
Grants
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,308,833 · 2
By mechanism
R44$4,308,833 · 2
Investigators at Transcode Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Clinical Development of First-in-Class Therapy for Metastatic Breast Cancer$1,129,316
R44 · FY2022 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer$1,011,207
R44 · FY2024 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer$988,765
R44 · FY2025 · CA
Clinical Development of First-in-Class Therapy for Metastatic Breast Cancer$870,684
R44 · FY2023 · CA
Clinical Development of First-in-Class Therapy for Metastatic Breast Cancer$308,861
R44 · FY2021 · CA